4.7 Article

Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment

Journal

JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume 9, Issue 4, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jitc-2020-002297

Keywords

colorectal cancer; anti-tumor immunity; myeloid cells; innate immunity; spatial analysis; tumor microenvironment

Funding

  1. US National Institutes of Health (NIH) [P01 CA87969, UM1 CA186107, P01 CA55075, UM1 CA167552, U01 CA167552, P50 CA127003, R01 CA118553, R01 CA169141, R01 CA137178, K24 DK098311, R35 CA197735, R01 CA151993, R01 CA248857, K07 CA190673, R03 CA197879, R21 CA222940, R21 CA230873, K07 CA188126]
  2. Nodal Award from Dana-Farber Harvard Cancer Center [2016-02]
  3. Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant [SU2C-AACR-DT22-17]
  4. Project P Fund
  5. Friends of the Dana-Farber Cancer Institute
  6. Bennett Family Fund
  7. Entertainment Industry Foundation through National Colorectal Cancer Research Alliance
  8. Uehara Memorial Foundation
  9. Mitsukoshi Health and Welfare Foundation
  10. Finnish Cultural Foundation
  11. Orion Research Foundation
  12. Australia Awards-Endeavour Scholarships and Fellowships Program
  13. Overseas Research Fellowship from Japan Society for the Promotion of Science [JP201860083]
  14. Investigator Initiated Grant from the American Institute for Cancer Research
  15. Douglas Gray Woodruff Chair fund
  16. Guo Shu Shi Fund
  17. Anonymous Family Fund for Innovations in Colorectal Cancer
  18. George Stone Family Foundation
  19. Conquer Cancer Foundation of ASCO Career Development Award

Ask authors/readers for more resources

Myeloid cell populations in the colorectal cancer microenvironment exhibit spatially distinct distributions and subset-specific prognostic significance. Mature CD14(+)HLA-DR+ and immature CD14(+)HLA-DR- monocytic phenotypes show opposite associations. These findings underscore the prognostic utility of multimarker evaluation of myeloid cell infiltrates and reveal a previously unrecognized degree of spatial organization for myeloid cells in the immune microenvironment.
Background Myeloid cells represent an abundant yet heterogeneous cell population in the colorectal cancer microenvironment, and their roles remain poorly understood. Methods We used multiplexed immunofluorescence combined with digital image analysis to identify CD14(+) monocytic and CD15(+) granulocytic cells and to evaluate their maturity (HLA-DR and CD33), immunosuppressive potential (ARG1) and proximity to cytokeratin (KRT)-positive tumor cells in 913 colorectal carcinomas. Using covariate data of 4465 incident colorectal cancers in two prospective cohort studies, the inverse probability weighting method was used with multivariable-adjusted Cox proportional hazards models to assess cancer-specific mortality according to ordinal quartiles (Q1-Q4) of myeloid cell densities. Immune cell-tumor cell proximity was measured with the nearest neighbor method and the G-cross function, which determines the likelihood of any tumor cell having at least one immune cell of the specified type within a certain radius. Results Higher intraepithelial (P (trend)=0.0002; HR for Q4 (vs Q1), 0.48, 95% CI 0.31 to 0.76) and stromal (P (trend) <0.0001; HR for Q4 (vs Q1), 0.42, 95% CI 0.29 to 0.63) densities of CD14(+)HLA-DR+ cells were associated with lower colorectal cancer-specific mortality while, conversely, higher intraepithelial densities of CD14(+)HLA-DR- cells were associated with higher colorectal cancer-specific mortality (P (trend)=0.0003; HR for Q4 (vs Q1), 1.78, 95% CI 1.25 to 2.55). Spatial analyses indicated that CD15(+) cells were located closer to tumor cells than CD14(+) cells, and CD14(+)HLA-DR+ cells were closer to tumor than CD14(+)HLA-DR- cells (p<0.0001). The G-cross proximity measurement, evaluating the difference in the likelihood of any tumor cell being colocated with at least one CD14(+)HLA-DR+ cell versus CD14(+)HLA-DR- cell within a 20 mu m radius, was associated with lower colorectal cancer-specific mortality (P (trend) <0.0001; HR for Q4 (vs Q1), 0.37, 95% CI 0.24 to 0.57). Conclusions Myeloid cell populations occur in spatially distinct distributions and exhibit divergent, subset-specific prognostic significance in colorectal cancer, with mature CD14(+)HLA-DR+ and immature CD14(+)HLA-DR- monocytic phenotypes most notably showing opposite associations. These results highlight the prognostic utility of multimarker evaluation of myeloid cell infiltrates and reveal a previously unrecognized degree of spatial organization for myeloid cells in the immune microenvironment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available